Sort
130,381 grants matching “hiv”
CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine SDMC
$1,414,274Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
Medical Sciences Campus Clinical Research Development P*
$1,414,137University Of Puerto Rico Med Sciences · P20 · FY2005 · RR
Immunophilin ligands for HIV dementia and neuropathy
$1,414,090Johns Hopkins University · P01 · FY2003 · MH
Therapeutic Vaccination for HIV Using VEE Vectors
$1,413,970University Of North Carolina Chapel Hill · P01 · FY2004 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,413,801Richard A Koup · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
UCSF Prevention Research Center
$1,413,770Marguerita A Lightfoot · University Of California, San Francisco · U48 · FY2014 · DP
Johns Hopkins AIDS Clinical Trials Unit
$1,413,300Charles W. Flexner · Johns Hopkins University · U01 · FY2009 · AI
Strategies to improve the HIV care continuum among key populations in India
$1,413,255Gregory M Lucas · Johns Hopkins University · R01 · FY2020 · DA
Component: Husbandry and Management Core
$1,412,907Kamm Prongay · Oregon Health & Science University · U42 · FY2020 · OD
Component: Husbandry and Management Core
$1,412,907Kamm Prongay · Oregon Health & Science University · U42 · FY2022 · OD
Component: Husbandry and Management Core
$1,412,907Kamm Prongay · Oregon Health & Science University · U42 · FY2021 · OD
Component: Husbandry and Management Core
$1,412,906Kamm Prongay · Oregon Health & Science University · U42 · FY2023 · OD
Develomental Core
$1,412,862Sarah M Fortune · Harvard Medical School · P30 · FY2014 · AI
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination
$1,412,696Dan H. Barouch · Beth Israel Deaconess Medical Center · P01 · FY2023 · AI
Southern Consortium Node of the Clinical Trials Network
$1,412,418Kathleen Theresa Brady · Medical University Of South Carolina · U10 · FY2014 · DA
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
$1,412,385Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2023 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,412,303Karen D. Sams · Ky St Cabinet/Health/Family Services · U62 · FY2015 · PS
Texas Repository for AIDS Neuropathogenesis Research
$1,412,231Benjamin B. Gelman · University Of Texas Med Br Galveston · R24 · FY2007 · NS
CDU/UCLA Project EXPORT Center
$1,412,151David Sane Martins · Charles R. Drew University Of Med & Sci · P20 · FY2016 · MD
UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)
$1,411,801Brad R Weiner · University Of Puerto Rico Med Sciences · U54 · FY2020 · CA
Optimization of HIV glycoproteins as vaccine candidates
$1,411,724Jose A Lasalde-Dominicci · University Of Puerto Rico · R01 · FY2019 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,411,698David B Clifford · Washington University · U01 · FY2006 · AI
Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection
$1,411,489Robert L Cook · University Of Florida · P01 · FY2021 · AA
NUTRITION AND HIV INFECTION
$1,411,402Tufts University Boston · P01 · FY2002 · DK
The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
$1,411,395Jeffrey H Samet · Boston Medical Center · P01 · FY2024 · AA